The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-London stocks slip on fears of second virus wave; BP slides

Mon, 15th Jun 2020 09:29

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* BP tumbles on writing off up to $17.5 bln in asset value

* Miners, energy stocks lead declines

* Bunzl jumps on upbeat revenue forecast

* FTSE 100 down 0.7%, FTSE 250 up 0.07%
(Adds comment, updates to close)

June 15 (Reuters) - London's FTSE 100 fell on Monday but
ended well off session lows, and mid-caps cut all their losses
towards the close after a surge in new cases of the novel
coronavirus in Beijing and underwhelming data from China knocked
markets at open.

Leading losses among European peers, the FTSE 100 closed
down 0.7% but recovered from a three-week low hit during the
session.

BP Plc weighed the most on the commodity-heavy index,
sliding 2.2% after saying it would write off up to $17.5 billion
in the value of its assets. A drop in base metal prices also
weighed.

Topping the FTSE 100, business supplies distributor Bunzl
jumped 9.8% after forecasting an increase in revenue
for the first half of the year, while AstraZeneca rose
1%.

The mid-cap FTSE 250 index ended flat as losses in
mining and some consumer stocks were offset by
gains in financials and defensive sectors such as real estate
and utilities.

Concerns of a slower economic recovery rose as Beijing
reinstated curbs after an unexpected spike in cases, and on
downbeat China factory data. In Britain, data showed footprint
in shopping centres fell nearly 82% from a year earlier.

The travel sector, one of the biggest
casualties of the pandemic-driven slump in demand, was off 1.3%.
Low-cost airline easyJet shed 4.6% even as it resumed
flying for the first time since March 30.

UK stock markets last week halted a robust two-month rally
as optimism around easing lockdowns was dulled by a grim
forecast by the U.S. Federal Reserve and a resurgence in
COVID-19 cases.

Investors now await the Bank of England meeting later this
week.

"We expect them to leave the policy rate unchanged at 0.1%
and to add 100 billion of quantitative easing purchases," said
Peder Beck-Friis, portfolio manager, global macro at PIMCO, who
sees negative rates as unlikely.
(Reporting by Sagarika Jaisinghani, Shashank Nayar and Susan
Mathew in Bengaluru; additional reporting by Aaron Saldanha;
editing by Uttaresh.V; editing by Jonathan Oatis)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.